Progress – Soft Bones

Whole genome sequencing in adults with clinical hallmarks of hypophosphatasia negative for ALPL variants

To read more please click on the link below. Read Article

Margaret Robb November 12, 2024

0 Comments

Safety, pharmacokinetics, and pharmacodynamics of efzimfotase alfa, a second-generation enzyme replacement therapy: phase 1, dose-escalation study in adults with hypophosphatasia

To read more please click on the link below. Read Article

Margaret Robb November 12, 2024

0 Comments

Prevalence of chondrocalcinosis and calcium pyrophosphate deposition disease in a cohort of adult patients with low alkaline phosphatase levels and a positive versus negative genetic ALPL study

To read more please click on the link below. Read Article

Margaret Robb November 12, 2024

0 Comments

Gene Therapy for Hypophosphatasia: Current Management and Future

To read more please click on the link below. Read Article

Margaret Robb August 15, 2024

0 Comments

Mail Address (P.O Box)
The US Hypophosphatasia Foundation
141 Hawkins Place, #267
Boonton, NJ 07005, USA.

Organization

Programs

Community

Office Address (Location for meetings and events)
1719 NJ-10, Suite 315
Parsippany, NJ 07054

Follow Us on Social Media!

Disclaimer: This Website is owned by Soft Bones, Inc. All materials contained in this Website (the “Materials”) are either owned by or licensed to us and are protected by intellectual property and other laws. We retain all proprietary rights to the Materials. This Website is copyrighted. All rights are reserved. Except as expressly authorized by us, any use, copy, reproduction, display, performance, modification or retransmission of the Materials is strictly prohibited.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31